Meet our team

Our team is a comprehensive mixture of experienced entrepreneurs and recognised scientists. Our strength is the combined expertise in life sciences and medical sector, as well as in computer technology and business-to-business software industry. We are committed to helping our customers of any size to build the solutions they need for virtual microscopy.

Kaisa Helminen

Kaisa Helminen

CEO

Kaisa Helminen is the CEO of Fimmic. Kaisa joined Fimmic in 2014 and has previously worked for international companies Sartorius, Thermo Fisher Scientific Inc. and a Finnish biotech company Finnzymes Oy.

Kaisa has a strong background in life science sector where she has gained more than 15 years of experience in the global business. She has experience in global sales, marketing and strategic product management in molecular biology field, as well as in liquid handling instruments and consumables business. Kaisa has a proven track record in creating and executing business plans and strategies, launching new products and working productively with various global sales channels.

Kaisa holds a M.Sc. degree in Biochemistry from the University of Helsinki.

Johan Lundin

Johan Lundin

CSO, Co-founder

Johan Lundin (MD, PhD) is one of the founders of Fimmic and a board member. At Fimmic Johan works as the Chief Scientific Officer.

He is a Research Director at Finnish Institute of Molecular Medicine (FIMM) at University of Helsinki and a guest professor at Karolinska Institutet in Stockholm. Johan is involved in infrastructure programs at the national level (Biocenter Finland) and in the international ESFRI networks (EATRIS), which operate research services for scientists, clinicians and industry.

As a Research Director at FIMM Johan coordinates translational research projects and collaborations with all FIMM partner organizations, national collaborators and international networks, including academia and industry. Translational research and personalized medicine are key areas at FIMM.

Johan has a special interest in using information and communication technologies (ICT) for improvement of diagnostics and care of the individual patient. He has developed technologies for diagnostic decision support with cloud-based and mobile solutions that allow the diagnostic process to be performed remotely, by a human observer or using automated computerized analysis.

Mikael Lundin

Mikael Lundin

Director of Concept Design, Co-founder

Mikael Lundin (MD) is one of the founders and a board member at Fimmic. Mikael works as the Director of Concept Design at Fimmic and he is a researcher in Translational Genomics at Finnish Institute for Molecular Medicine (FIMM), which is part of University of Helsinki.

Mikael can be considered one of the pioneers of web-based virtual microscopy and has launched the first practical applications already in 2002. He has published a series of central studies in virtual microscopy together with key opinion leaders in related fields. Mikael is fluent in a wide range of programming languages and techniques, and he has a special interest in database design and imaging.

Between 2008 and 2012 Mikael represented Finland in the EURO-TELEPATH (Anatomic Telepathology Network) COST Action.

Kari Pitkänen

Kari Pitkänen

Director of Business Development, Co-founder

Kari Pitkänen is one of the founders of Fimmic and a board member. Kari works as a Director of Business Development at Fimmic. He is also a board member in Finnish Bioindustries FIB (Finnish Biotechnology Industry Association).

Kari was one of the founders and Director of Marketing in Finnzymes Oy for 25 years until 2011. Finnzymes Oy was a Finnish private biotech company, which manufactured PCR related enzymes and kits for global molecular biology research and animal diagnostics market. Finnzymes Oy was acquired by Thermo Fisher Scientific Inc. in 2010.

Kari holds a M.Sc. degree from the Helsinki University of Technology.

Mikael Jääskeläinen

Mikael Jääskeläinen

Sales Manager

Mikael Jääskeläinen is responsible for global sales and customer relations management for Fimmic. Mikael joined Fimmic in March 2014 having previously worked for international companies Sartorius, Thermo Fisher Scientific Inc. and Finnish biotech company Finnzymes Oy.

Mikael has more than 20 years of experience in sales and marketing in the life science sector. He has gained a broad experience in sales processes and channels, customer service and marketing actions.

Tuomas Ropponen

Tuomas Ropponen

Chief Technology Officer

Tuomas Ropponen is responsible for development of the WebMicroscope platform. Tuomas joined Fimmic in May 2016 having previously worked for international companies Outotec and Sartorius Biohit. Tuomas was one of the founder of Delta-Enterprise that is now known as Roima Intelligence Inc.

Tuomas holds a M.Sc. degree in automation IT from Helsinki University of Technology.

Antti Merivirta

Antti Merivirta

Marketing Coordinator

Antti Merivirta is responsible for coordinating marketing actions at Fimmic. Antti joined Fimmic in November 2015 having previously worked at 360Visualizer and Testure.

Antti has gained a broad experience in visual marketing for digital channels and Inbound marketing.

Antti holds a M.Sc. degree in Digital Marketing from Aalto University School of Business.

Meet our board

Our board is a comprehensive mixture of experienced entrepreneurs and business leaders. The board offers us wide ranging expertise in life sciences, medical sector and business-to-business software industry, as well as strategic leadership from large global companies to startups.

Pekka Mattila

Pekka Mattila

Chairman of the board

Pekka Mattila is the CEO of Desentum Oy. He holds board positions in several biotech and pharmaceutical companies including Fimmic, Herantis Pharma, Medix Biochemica and Mobidiag.

Pekka has extensive experience in leading and managing biotech companies. He was one of the founders of the Finnzymes Group and served as its CEO for 25 years until acquisition by Thermo Fisher Scientific Inc. in 2010. He was the president of Finnzymes Group since 2009.

Pekka holds a Master’s degree from Helsinki University of Technology in biochemistry, biotechnology and microbiology.

Johan Lundin

Johan Lundin

CSO, Co-founder

Johan Lundin (MD, PhD) is one of the founders of Fimmic and a board member. At Fimmic Johan works as the Chief Scientific Officer.

He is a Research Director at Finnish Institute of Molecular Medicine (FIMM) at University of Helsinki and a guest professor at Karolinska Institutet in Stockholm. Johan is involved in infrastructure programs at the national level (Biocenter Finland) and in the international ESFRI networks (EATRIS), which operate research services for scientists, clinicians and industry.

As a Research Director at FIMM Johan coordinates translational research projects and collaborations with all FIMM partner organizations, national collaborators and international networks, including academia and industry. Translational research and personalized medicine are key areas at FIMM.

Johan has a special interest in using information and communication technologies (ICT) for improvement of diagnostics and care of the individual patient. He has developed technologies for diagnostic decision support with cloud-based and mobile solutions that allow the diagnostic process to be performed remotely, by a human observer or using automated computerized analysis.

Mikael Lundin

Mikael Lundin

CTO, Co-founder

Mikael Lundin (MD) is one of the founders and a board member at Fimmic. Mikael works as the Chief Technology Officer at Fimmic and he is a researcher in Translational Genomics at Finnish Institute for Molecular Medicine (FIMM), which is part of University of Helsinki.

Mikael can be considered one of the pioneers of web-based virtual microscopy and has launched the first practical applications already in 2002. He has published a series of central studies in virtual microscopy together with key opinion leaders in related fields. Mikael is fluent in a wide range of programming languages and techniques, and he has a special interest in database design and imaging.

Between 2008 and 2012 Mikael represented Finland in the EURO-TELEPATH (Anatomic Telepathology Network) COST Action.

Kari Pitkänen

Kari Pitkänen

Director of Business Development

Kari Pitkänen is one of the founders of Fimmic and a board member. Kari works as a Director of Business Development at Fimmic. He is also a board member in Finnish Bioindustries FIB (Finnish Biotechnology Industry Association).

Kari was one of the founders and Director of Marketing in Finnzymes Oy for 25 years until 2011. Finnzymes Oy was a Finnish private biotech company, which manufactured PCR related enzymes and kits for global molecular biology research and animal diagnostics market. Finnzymes Oy was acquired by Thermo Fisher Scientific Inc. in 2010.

Kari holds a M.Sc. degree from the Helsinki University of Technology.

Timo Soininen

Timo Soininen

Board member

Timo Soininen is the CEO and co-founder of Small Giant Games and a board member at Fimmic. Timo also holds board positions in Fingertip Ltd and Spinnova Ltd.

Timo is an experienced international Digital Growth Executive and a startup activist with a strong concept building background. He specializes in creating innovative growth strategies, plans and international teams to reach ambitious targets.

Timo holds a M.Sc. degree from the Helsinki School of Economics.

Jukka Tapaninen

Jukka Tapaninen

Board member

Jukka Tapaninen is an experienced IT business executive and a board member at Fimmic. Jukka also holds board positions at weVision, Addoro Ab, Findity and MeshWorks Wireless Oy.

Jukka has a strong background in the IT industry on managing companies and business units globally. His leadership experience, from large companies like SAP and HP, as well as from strong midsize companies has given him industry knowledge and excellent network within the strategic ecosystem and major customers. Jukka has experience in working in the United States, Singapore and multiple locations in Europe that have given him a good understanding on how business is done in different parts of the world.

Jukka holds a M.Sc. degree from the Helsinki School of Economics.

Tuomas Tenkanen

Tuomas Tenkanen

Board member

Tuomas Tenkanen is the CEO of Mobidiag and a Fimmic board member.

Tuomas is a business and research professional with more than 25 years of experience from leadership positions in high-tech life science companies. He served as the Director of R&D at Finnzymes Oy, one of the Leading PCR technology companies, acquired by Thermo Fisher Scientific Inc. in 2010.

Tuomas holds a M.Sc. degree from the Helsinki University of Technology.

Pin It on Pinterest